Plasma homocysteine levels are associated with ulceration of the foot in patients with type 2 diabetes mellitus

Diabetes/Metabolism Research and Reviews

Volumn 26, Issue 2, 2010, Pages 115-120

  Gonzalez R ^a,b   Pedro, T ^a   Real, Jose T ^a,c,d   Martinez Hervas S ^a,c,d   Abellan M R ^c   Lorente, R ^a   Priego, A ^a   Catala M ^a,d   Chaves, F J ^c,d   Ascaso, J F ^a,c,d   Carmena, R ^a,c,d  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^b Centro Salud Trafalgar   (Spain)

^c UNIVERSITY OF VALENCIA   (Spain)

^d INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Diabetic foot ulceration; Microalbuminuria; Plasma homocysteine; Type 2 diabetes mellitus

Indexed keywords

APOLIPOPROTEIN B; CYANOCOBALAMIN; FOLIC ACID; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETIC FOOT; DISEASE ASSOCIATION; DYSLIPIDEMIA; FEMALE; FOOT ULCER; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RISK FACTOR;

ADULT; AGED; ALBUMINURIA; APOLIPOPROTEINS B; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC FOOT; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HOMOCYSTEINE; HUMANS; MALE; MIDDLE AGED; PERIPHERAL VASCULAR DISEASES; RISK;

EID: 77950438789     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.1061     Document Type: Article

References (34)

1. Reiber GE. The epidemiology of diabetic foot problems. Diabet Med 1996; 13(Suppl. 1): S6-S11.
2. Gibbons GM, Eliopoulos GM. Infection of the diabetic foot. In Management of Diabetic Foot Problems (2nd edn), Kozak GP, Campbell DR, Frykberg RG, Habershaw GM (eds). WB Saunders: Philadelphia, 1995; 121-129.
3. Most RS, Sinnock P. The epidemiology of lower extremity amputations in diabetic individuals. Diabetes Care 1983; 6: 87-91.
4. Armstrong DG, Lavery LA, Quebedeaux TL, Walker SC. Surgical morbidity and the risk of amputation due to infected puncture wounds in diabetic versus nondiabetic adults. South Med J 1997; 90: 384-389.
5. Boyko EJ, Ahroni JH, Smith DG, Davignon DR. Increased mortality associated with diabetic foot ulcer. Diabet Med 1996; 13: 967-972.
6. Pecoraro R, Reiber G, Burgess E. Pathways to diabetic limb amputation: a basis for prevention. Diabetes Care 1990; 13: 513-521.
7. Lavery LA, Armstrong DG, Vela SA, Quebedeaux TL, Fleischli JG. Practical criteria for screening patients at high risk for diabetic foot ulceration. Arch Intern Med 1998; 158: 157-162.
8. Boyko EJ, Ahroni JH, Stensel V, Forsberg RC, Davignon DR, Smith DG. A prospective study of risk factors for diabetic foot ulcer: the Seattle Diabetic Foot Study. Diabetes Care 1999; 22: 1036-1042.
9. Pham H, Armstrong DG, Harvey C. Screening techniques to identify people at high risk for diabetic foot ulceration. Diabetes Care 2000; 23: 606-611.
10. Matricali GA, Dereymaeker G, Muls E, Flour M, Mathieu C. Economic aspects of diabetic foot care in a multidisciplinary setting: a review. Diabetes Metab Res Rev 2007; 23: 339-347.
11. Pradham AD, Shrivastavas S, Cook NR, Rifai N, Creager MA, Ridker PM. Symptomatic peripheral arterial disease in women: non-traditional biomarkers of elevated risk. Circulation 2008; 117: 823-831.
12. Garofolo L, Barros N Jr, Miranda F Jr, D'almeida V, Cardien LC, Ferreira SR. Association of increased levels of homocysteine and peripheral arterial disease in a Japanase-Brazilian population. Eur J Vasc Endovasc Surg 2007; 34: 23-28.
13. Bruce SG, Young TK. Prevalence and risk factors for neuropathy in a Canadian First Nation community. Diabetes Care 2008; 31: 1837-1841.
14. Wagner FW Jr. The dysvascular foot: a system for diagnosis and treatment. Foot Ankle 1981; 2: 64-122.
15. Boulton AJ. Lowering the risk of neuropathy, foot ulcers and amputations. Diabet Med 1988; 15(Suppl. 4): S57-59.
16. Dyck PJ. Detection, characterization, and staging of poly-neuropathy: assessed in diabetics. Muscle Nerve 1988; 11: 21-32.
17. Ascaso JF, Merchante A, Lorente RI, Real JT, Martinez Valls J, Carmena R. A study of insulin resistance, using the minimal model, in non-diabetic familial combined hyperlipidemic patients. Metabolism 1998; 47: 508-513.
18. Friedewald WT, Levy RI, Fredickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
19. National Cholesterol Education Program (NCEP). Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Adult Treatment Panel III final report. Circulation 2002; 106: 3143-3421.
20. Shing N, Armstrong DG, Lipsky B. Preventing foot ulcers in patients with diabetes. JAMA 2005; 293: 217-228.
21. Boushey CJ. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. JAMA 1995; 274: 1049-1057.
22. Genest JJ, McNamara JR. Plasma homocysteine levels in men with premature coronary artery disease. J Am Coll Cardiol 1990; 16: 114-119.
23. Allison MA, Criqui MH, McClelland RL, et al. The effect of novel cardiovascular risk factors on the ethnic-specific odds for peripheral arterial disease in the multi-ethnic study of atherosclerosis (MESA). J Am Coll Cardiol 2006; 48: 1190-1197.
24. Sofi F, Lari B, Rogolino A, et al. Thrombophilic risk factors for symptomatic peripheral arterial disease. J Vasc Surg 2005; 41: 255-260.
25. Papatheodorou L, Weiss N. Vascular oxidant stress and inflammation in hyperhomocysteinemia. Antioxid Redox Signal 2007; 9: 1941-1958.
26. Weir DG, Scott JM. The biochemical basis of neuropathy in cobalamin deficiency. Baillieres Clin Heamatol 1995; 8: 479-497.
27. Schlussel E, Preibisch G, Putter S, Elstner EF. Homocysteine-induced oxidative damage: mechanisms and possible roles in neurodegenerative and atherogenic processes. Z Naturforsch C 1995; 50c: 699-707.
28. Ambrosch A, Dierkes J, Lobmann R, et al. Relation between homocysteinaemia and diabetic neuropathy in patients with type 2 diabetes mellitus. Diabetic Medicine 2001; 18: 185-192.
29. Hoogeveen EK, Kostense PJ, Valk GD, et al. Hyperhomocysteinaemia is not related to risk of distal somatic polyneuropathy: the Hoorn study. J Intern Med 1999; 246: 561-566.
30. Dinneen SF, Gerstein HC. The association of microalbuminuria and mortality in non insulin-dependent diabetes mellitus: a systematic overview of the literature. Arch Intern Med 1997; 157: 1413-1418.
31. The Diabetes Control and Complications Trial Research Group. Factors in the development of diabetic neuropathy: baseline analysis of neuropathy in the feasibility phase of the diabetes complications trial (DCCT). Diabetes 1988; 37: 476-481.
32. Singh N, Armstrong D. Preventing foot ulcers in patients with diabetes. JAMA 2005; 293: 217-228.
33. De Sonnaville JJ, Bouma M. Sustained good control in NIDDM patients by implementation of structured care in general practice: 2-year follow-up study. Diabetologia 1997; 40: 1334-1340.
34. Lavery LA, Armstrong DG, Vela SA. Practical criteria for screening patients at high risk for diabetic foot ulceration. Arch Intern Med 1998; 158: 157-162.